इंसान की नकल करने में माहिर है पहाड़ी मैना, जानें इस पक्षी से जुड़ी और दिलचस्प बातें

पहाड़ी मैना (Hill Myna) एक सामाजिक परिंदा है जो छोटे-छोटे झुंड और जोड़े में रहना पसंद...

from NDTV Khabar - Latest https://ift.tt/30bB69q
via IFTTT

Read More

Vehicles Accounted For 50% Delhi Pollution In Early Winter, Says Report

Vehicles accounted for more than 50 per cent of Delhi's pollution during the early phase of this year's winter, from October 24 to November 8, according to an analysis by the green think tank Centre...

from NDTV News - India-news https://ift.tt/3onpaK6
via IFTTT

Read More

Chief Of Defence Staff, Foreign Ministry's Different Take On China Row

Chief of Defence Staff (CDS) Bipin Rawat today said the controversy about the Chinese coming into the Indian territory and building a new village is "not true", and that the villages were well within...

from NDTV News - India-news https://ift.tt/3qtGksn
via IFTTT

Read More

Salman Khurshid Told Off By Congress Colleague In "Hindutva" Row

The BJP has found a surprise ally in their condemnation of Congress leader Salman Khurshid's new book on the Ayodhya verdict by the Supreme Court. Unexpected criticism of Mr Khurshid's views came...

from NDTV News - India-news https://ift.tt/30h0FFZ
via IFTTT

Read More

Court Orders Framing Of Charges Against AAP MLA In Doctor Suicide Case

A Delhi court on Thursday ordered framing of abetment of suicide, extortion, and other charges against AAP MLA Prakash Jarwal in connection with a case of the alleged suicide of a doctor in south...

from NDTV News - India-news https://ift.tt/3F8Czww
via IFTTT

Read More

BJP Spent Rs 252 Crore In Poll Campaign In 5 States, 60% Of It In Bengal

The BJP spent Rs 252 crore in the assembly elections held in Assam, Puducherry, Tamil Nadu, West Bengal and Kerala earlier this year with almost 60 per cent used for campaigning in the Trinamool...

from NDTV News - India-news https://ift.tt/3Dn6lNH
via IFTTT

Read More

Game Changing Made-In-India Anti-Covid Pills Could Be Cleared In Days

Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the...

from NDTV News - India-news https://ift.tt/3D6f5aL
via IFTTT

Read More